A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2015
The Primary objective is to assess the non-inferiority of the experimental arm (arm B) compared to the control arm (arm A) in terms of Major Molecular Response (MMolR) after the 4th cycle (MRD4) in patients aged 18-59 years old with de novo Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL)
Epistemonikos ID: a5dcb07332238aee89b348b0b6e349e2ea8ef80d
First added on: Jan 21, 2022